or
forgot password

    • cancer clinical trials in concord, MA

    • Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
    Bethke Cancer Center at Emerson Hospital
    Concord, Massachusetts 01742
    Breast Cancer
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Commonwealth Hematology-Oncology, PC - Concord
    Concord, Massachusetts 01742
    Breast Cancer
    Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
    Bethke Cancer Center at Emerson Hospital
    Concord, Massachusetts 01742
    Breast Cancer
    Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
    Emerson Hospital
    Concord, Massachusetts 01742
    Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    Radiation Therapy, Carboplatin, and Paclitaxel With or Without Amifostine in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer
    Bethke Cancer Center at Emerson Hospital
    Concord, Massachusetts 01742
    Chemotherapeutic Agent Toxicity, Head and Neck Cancer, Mucositis, Radiation Toxicity, Xerostomia
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Commonwealth Hematology Oncology PC-Concord
    Concord, Massachusetts 01742
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Commonwealth Hematology Oncology PC-Concord
    Concord, Massachusetts 01742
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Commonwealth Hematology-Oncology, PC - Concord
    Concord, Massachusetts 01742
    Breast Cancer
    Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC)
    GTx Investigative Site
    Concord, Massachusetts 01742
    Muscle Wasting, Non Small Cell Lung Cancer
    Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum
    GTx Investigative Site
    Concord, Massachusetts 01742
    Muscle Wasting, Non-Small Cell Lung Cancer
    Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
    Bethke Cancer Center at Emerson Hospital
    Concord, Massachusetts 01742
    Anal Cancer
    Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer
    Bethke Cancer Center at Emerson Hospital
    Concord, Massachusetts 01742
    Breast Cancer, Osteoporosis
    Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer
    Emerson Hospital
    Concord, Massachusetts 01742
    Prostate Cancer